CV Lattes
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Odontologia from Universidade Estadual de Montes Claros (2009), master's at Odontology from Universidade Estadual de Campinas (2012) and doctorate at Odontology from Universidade Estadual de Campinas (2015). , acting on the following subjects: clear cell change, immunohistochemistry, signet-ring cell change, mucocele and lip. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Gefitinib is an epidermal growth factor receptor (EGFR) inhibitor that was originally approved by the Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer (NSCLC). Studies evaluating the expression of EGFR in hematopoietic precursors do not present unanimous results. Patients with synchronous NSCLC and acute myeloid leukemia (AML) treated with gefitinib had r…
The epidermal growth factor receptor (EGFR) is an important regulator of cell proliferation and differentiation. Changes in EGFR expression are associated with tumor growth and metastasis in solid tumors. On the other hand, there is scarce information in the literature about the participation of the EGFR pathway in hematological malignancies, including acute myeloid leukemia (AML). A prev…
Fatty acid synthase (FASN) is the enzyme responsible for the de novo biosynthesis of fatty acids (FA). Its expression is high in several malignancies, including oral squamous cell carcinoma (OSCC). FASN overexpression has been associated with high recurrence rates, increased risk of metastasis, lower survival rates and consequently poor prognosis in several human cancers. Orlistat (Xenica…
| 3 / 3 | Completed scholarships in Brazil |
| Associated processes | |